Association of bacterial community types, functional microbial processes and lung disease in cystic fibrosis airways

[1]  J. Lipuma,et al.  Parallel Analysis of Cystic Fibrosis Sputum and Saliva Reveals Overlapping Communities and an Opportunity for Sample Decontamination , 2020, mSystems.

[2]  Gavin M Douglas,et al.  PICRUSt2 for prediction of metagenome functions , 2020, Nature Biotechnology.

[3]  L. Hoffman,et al.  Lung function and microbiota diversity in cystic fibrosis , 2020, Microbiome.

[4]  Bradley S. Turner,et al.  Mucin glycans attenuate the virulence of Pseudomonas aeruginosa in infection , 2019, Nature Microbiology.

[5]  S. Widder,et al.  Microbial Metabolites in Cystic Fibrosis: A Target for Future Therapy? , 2019, American journal of respiratory cell and molecular biology.

[6]  Richard M Leggett,et al.  Nanopore metagenomics enables rapid clinical diagnosis of bacterial lower respiratory infection , 2019, Nature Biotechnology.

[7]  C. Goss,et al.  Direct Lung Sampling Indicates That Established Pathogens Dominate Early Infections in Children with Cystic Fibrosis. , 2019, Cell reports.

[8]  Rob Knight,et al.  Niche partitioning of a pathogenic microbiome driven by chemical gradients , 2018, Science Advances.

[9]  L. Fajas,et al.  Dietary Fiber Confers Protection against Flu by Shaping Ly6c− Patrolling Monocyte Hematopoiesis and CD8+ T Cell Metabolism , 2018, Immunity.

[10]  M. Rogers,et al.  Fluctuations in airway bacterial communities associated with clinical states and disease stages in cystic fibrosis , 2018, PloS one.

[11]  William R. Harcombe,et al.  Cross-feeding modulates antibiotic tolerance in bacterial communities , 2018, The ISME Journal.

[12]  L. Hoffman,et al.  How can the cystic fibrosis respiratory microbiome influence our clinical decision-making? , 2017, Current opinion in pulmonary medicine.

[13]  W. T. Harris,et al.  Airway microbiota across age and disease spectrum in cystic fibrosis , 2017, European Respiratory Journal.

[14]  Suzanne M. Paley,et al.  The MetaCyc database of metabolic pathways and enzymes , 2017, Nucleic Acids Res..

[15]  J. Galeano,et al.  Individual Patterns of Complexity in Cystic Fibrosis Lung Microbiota, Including Predator Bacteria, over a 1-Year Period , 2017, mBio.

[16]  Pan-Jun Kim,et al.  Global metabolic interaction network of the human gut microbiota for context-specific community-scale analysis , 2017, Nature Communications.

[17]  R. Hunter,et al.  Genome-Wide Survey of Pseudomonas aeruginosa PA14 Reveals a Role for the Glyoxylate Pathway and Extracellular Proteases in the Utilization of Mucin , 2017, Infection and Immunity.

[18]  M. Surette,et al.  Longitudinal sampling of the lung microbiota in individuals with cystic fibrosis , 2017, PloS one.

[19]  F. Rohwer,et al.  Ecological networking of cystic fibrosis lung infections , 2016, npj Biofilms and Microbiomes.

[20]  É. Vivier,et al.  The discontinuity theory of immunity , 2016, Science Immunology.

[21]  R. Hunter,et al.  Evidence and Role for Bacterial Mucin Degradation in Cystic Fibrosis Airway Disease , 2016, bioRxiv.

[22]  Casey M. Theriot,et al.  Metabolic Model-Based Integration of Microbiome Taxonomic and Metabolomic Profiles Elucidates Mechanistic Links between Ecological and Metabolic Variation , 2016, mSystems.

[23]  J. Lipuma,et al.  Culture-Based and Culture-Independent Bacteriologic Analysis of Cystic Fibrosis Respiratory Specimens , 2015, Journal of Clinical Microbiology.

[24]  Ahmed Abdul Azim,et al.  The Role of Short-Chain Fatty Acids, Produced by Anaerobic Bacteria, in the Cystic Fibrosis Airway. , 2015, American journal of respiratory and critical care medicine.

[25]  J. Kitzman,et al.  Regional Isolation Drives Bacterial Diversification within Cystic Fibrosis Lungs. , 2015, Cell host & microbe.

[26]  D. Newman,et al.  Pediatric Cystic Fibrosis Sputum Can Be Chemically Dynamic, Anoxic, and Extremely Reduced Due to Hydrogen Sulfide Formation , 2015, mBio.

[27]  Z. Abdo,et al.  The daily dynamics of cystic fibrosis airway microbiota during clinical stability and at exacerbation , 2015, Microbiome.

[28]  L. Tailford,et al.  Mucin glycan foraging in the human gut microbiome , 2015, Front. Genet..

[29]  L. Hoffman,et al.  Directly sampling the lung of a young child with cystic fibrosis reveals diverse microbiota. , 2014, Annals of the American Thoracic Society.

[30]  P. Schloss,et al.  Dynamics and associations of microbial community types across the human body , 2014, Nature.

[31]  Forest Rohwer,et al.  Biogeochemical Forces Shape the Composition and Physiology of Polymicrobial Communities in the Cystic Fibrosis Lung , 2014, mBio.

[32]  Deborah A Hogan,et al.  Unique microbial communities persist in individual cystic fibrosis patients throughout a clinical exacerbation , 2013, Microbiome.

[33]  J. Petrosino,et al.  Changes in cystic fibrosis airway microbiota at pulmonary exacerbation. , 2013, Annals of the American Thoracic Society.

[34]  A. Fodor,et al.  The Adult Cystic Fibrosis Airway Microbiota Is Stable over Time and Infection Type, and Highly Resilient to Antibiotic Treatment of Exacerbations , 2012, PloS one.

[35]  Jonathan Friedman,et al.  Inferring Correlation Networks from Genomic Survey Data , 2012, PLoS Comput. Biol..

[36]  S. Dowd,et al.  Direct sampling of cystic fibrosis lungs indicates that DNA-based analyses of upper-airway specimens can misrepresent lung microbiota , 2012, Proceedings of the National Academy of Sciences.

[37]  M. Sogin,et al.  Prevalence of Streptococci and Increased Polymicrobial Diversity Associated with Cystic Fibrosis Patient Stability , 2012, Journal of bacteriology.

[38]  L. Hoffman,et al.  Long-term cultivation-independent microbial diversity analysis demonstrates that bacterial communities infecting the adult cystic fibrosis lung show stability and resilience , 2012, Thorax.

[39]  Susan Murray,et al.  Decade-long bacterial community dynamics in cystic fibrosis airways , 2012, Proceedings of the National Academy of Sciences.

[40]  J. Petrosino,et al.  Impact of Enhanced Staphylococcus DNA Extraction on Microbial Community Measures in Cystic Fibrosis Sputum , 2012, PloS one.

[41]  C. Quince,et al.  Dirichlet Multinomial Mixtures: Generative Models for Microbial Metagenomics , 2012, PloS one.

[42]  Patrick D. Schloss,et al.  Reducing the Effects of PCR Amplification and Sequencing Artifacts on 16S rRNA-Based Studies , 2011, PloS one.

[43]  J. M. Dow,et al.  Bacterial cis-2-unsaturated fatty acids found in the cystic fibrosis airway modulate virulence and persistence of Pseudomonas aeruginosa , 2011, The ISME Journal.

[44]  J. Petrosino,et al.  Effect of Sample Storage Conditions on Culture-Independent Bacterial Community Measures in Cystic Fibrosis Sputum Specimens , 2011, Journal of Clinical Microbiology.

[45]  J. Parkhill,et al.  Partitioning core and satellite taxa from within cystic fibrosis lung bacterial communities , 2010, The ISME Journal.

[46]  Eoin L. Brodie,et al.  Airway Microbiota and Pathogen Abundance in Age-Stratified Cystic Fibrosis Patients , 2010, PloS one.

[47]  David J Van Horn,et al.  Introducing mothur: Open-Source, Platform-Independent, Community-Supported Software for Describing and Comparing Microbial Communities , 2009, Applied and Environmental Microbiology.

[48]  M. Konstan,et al.  Characterizing aggressiveness and predicting future progression of CF lung disease. , 2009, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[49]  James R. Cole,et al.  The Ribosomal Database Project: improved alignments and new tools for rRNA analysis , 2008, Nucleic Acids Res..

[50]  M. Surette,et al.  A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients , 2008, Proceedings of the National Academy of Sciences.

[51]  N. Pace,et al.  Molecular identification of bacteria in bronchoalveolar lavage fluid from children with cystic fibrosis , 2007, Proceedings of the National Academy of Sciences.

[52]  J. Lefante,et al.  The precision of longitudinal lung function measurements: monitoring and interpretation , 2005, Occupational and Environmental Medicine.

[53]  M. Grisham,et al.  Elevation of nitrotyrosine and nitrate concentrations in cystic fibrosis sputum , 2000, Pediatric pulmonology.

[54]  S. Lory,et al.  Phylogenetic and metabolic diversity of bacteria associated with cystic fibrosis , 2011, The ISME Journal.

[55]  J. Voynow,et al.  Respiratory tract mucin genes and mucin glycoproteins in health and disease. , 2006, Physiological reviews.